書誌事項
- タイトル別名
-
- THE MUTAGENICITY OF AM-715 IN VITRO
- AM 715 ノ in vitro ヘンイゲンセイ シケン
この論文をさがす
抄録
The mutagenicity of AM-715, a new antibacterial drug, was tested in vitro in various short-term assays, i. e., rec-Assay, AMES test and chromosomal aberration test of cultured mammalian cells.<BR>1. rec-Assay: The ability of AM-715 preferentially to inhibit the growth of DNA-repair-deficient bacteria was weaker than that of nalidixic acid.<BR>2. AMES test: AM-715 exhibited no demonstrable mutagenicity for S. typhimurium and E. coil in the absence or presence of the microsomal preparation (S-9) derived from rat livers.<BR>3. Cytotoxicity against Chinese hamster cells (CHL cells): The growth inhibition of the cells was not observed in treatment at 100μg/ml of AM-715 for 24 hours, but was observed at 300μg/ml. Whereas, no morphological change was observed on the cells of which the growth was inhibited by treatment at 300μg/ml for 48 hours.<BR>4. Chromosomal aberration test on CHL cells: The chromosomal aberrations of the cells treated at 200μg/ml of AM-715 with or without S-9 for 48 hours were not significantly different from those of untreated cells.<BR>5. Sister chromatid exchange (SCE) in human blood cells and Chinese hamster cells (Don cells): The signiificant increase in SCE was not observed on both cells treated with AM-715.<BR>Therefore it was suggested that AM-715 had no mutagenicity in mammalian cells.
収録刊行物
-
- CHEMOTHERAPY
-
CHEMOTHERAPY 29 (Supplement4), 938-945, 1981
公益社団法人 日本化学療法学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282681259571968
-
- NII論文ID
- 130004071713
-
- NII書誌ID
- AN00186653
-
- ISSN
- 18845894
- 00093165
-
- NDL書誌ID
- 2477475
-
- データソース種別
-
- JaLC
- NDL
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可